Gilead Sciences, Inc.
GILD
$66.76
$0.600.91%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
Weiss Ratings | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C- | |||
Reward Grade | B | |||
Rating Factors | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Good | |||
Growth Index | Good | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.35 | |||
Price History | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.51% | |||
30-Day Total Return | -4.24% | |||
60-Day Total Return | -12.58% | |||
90-Day Total Return | -11.06% | |||
Year to Date Total Return | -16.58% | |||
1-Year Total Return | -17.62% | |||
2-Year Total Return | 14.07% | |||
3-Year Total Return | 6.23% | |||
5-Year Total Return | 12.90% | |||
52-Week High % Change | -23.83% | |||
52-Week Low % Change | 0.06% | |||
Price | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $87.87 | |||
52-Week Low Price | $66.89 | |||
52-Week Low Price (Date) | Apr 17, 2024 | |||
52-Week High Price (Date) | Jan 19, 2024 | |||
Valuation | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 83.46B | |||
Enterprise Value | 99.52B | |||
Price/Earnings (TTM) | 14.91 | |||
Earnings Per Share (TTM) | 4.49 | |||
Earnings Per Share Growth | 23.16% | |||
Price/Earnings To Growth | 0.64 | |||
Price/Sales (TTM) | 3.10 | |||
Price/Book (Q) | 3.65 | |||
Enterprise Value/Revenue (TTM) | 3.67 | |||
Price | $69.58 | |||
Enterprise Value/EBITDA (TTM) | 7.96 | |||
Enterprise Value/EBIT | 10.15 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 1.26B | |||
Dividend Yield | 4.51% | |||
Div. Per Share (Most Recent) | $0.77 | |||
Dividend Per Share (TTM) | $3.02 | |||
Payout Ratio (TTM) | 67.25% | |||
Dividend Per Share (Most Recent) | $0.77 | |||
Company Info | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 650 574 3000 | |||
Address | 333 Lakeside Drive Foster City, CA 94404 | |||
Website | www.gilead.com | |||
Country | United States | |||
Year Founded | 1987 | |||
Profitability | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 36.17% | |||
Profit Margin | 20.88% | |||
Management Effectiveness | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 9.79% | |||
Return on Equity | 25.53% | |||
Income Statement | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 27.12B | |||
Total Revenue (TTM) | 27.12B | |||
Revenue Per Share | $21.59 | |||
Gross Profit (TTM) | 21.10B | |||
EBITDA (TTM) | 12.50B | |||
EBIT (TTM) | 9.81B | |||
Net Income (TTM) | 5.66B | |||
Net Income Avl. to Common (TTM) | 5.66B | |||
Total Revenue Growth (Q YOY) | -3.72% | |||
Earnings Growth (Q YOY) | -13.23% | |||
EPS Diluted (TTM) | 4.49 | |||
EPS Diluted Growth (Q YOY) | -13.13% | |||
Balance Sheet | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 8.35B | |||
Cash Per Share (Q) | $6.65 | |||
Total Current Assets (Q) | 16.09B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 22.75B | |||
Current Ratio (Q) | 1.426 | |||
Book Value Per Share (Q) | $18.33 | |||
Total Assets (Q) | 62.13B | |||
Total Current Liabilities (Q) | 11.28B | |||
Total Debt (Q) | 25.66B | |||
Total Liabilities (Q) | 39.38B | |||
Total Common Equity (Q) | 22.83B | |||
Cash Flow | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -2.27B | |||
Cash from Financing (TTM) | -5.13B | |||
Net Change in Cash (TTM) | 673.00M | |||
Levered Free Cash Flow (TTM) | 8.40B | |||
Cash from Operations (TTM) | 8.01B | |||